New study reveals why most life-long smokers never develop lung cancer

Lung cancer remains the leading cause of cancer-related deaths globally, with cigarette smoking as its primary driver. Chemical carcinogens like polycyclic aromatic hydrocarbons (PAHs) in tobacco smoke damage DNA, leading to mutations that drive cancer development.

Despite this clear connection, most smokers do not develop lung cancer. Recent studies suggest that some smokers possess protective mechanisms limiting DNA mutations, offering new insights into cancer prevention and early detection.

Epidemiological studies have long associated lung cancer risk with factors like total smoking dose, duration, and timing of cessation. Yet, 80-90% of lifelong smokers never develop lung cancer, with most smoking-related deaths occurring in older populations. To unravel this paradox, researchers have shifted their focus to molecular and genetic factors, seeking to identify specific mechanisms that protect some individuals from carcinogenesis.

Tumor cells in lung cancers from smokers typically harbor tens of thousands of somatic mutations. However, little is known about the mutation landscape in normal bronchial basal cells, the likely precursors of squamous cell carcinoma. These cells, located in the proximal airway, accumulate unique mutations throughout life.

Understanding these patterns requires single-cell whole-genome sequencing (WGS), a cutting-edge technique that accurately identifies mutations without introducing errors during cell expansion.

Recent advances have allowed researchers to systematically analyze mutational burdens in lung cells from both smokers and non-smokers. By sequencing individual cells from a diverse cohort, scientists can now quantify the effects of age and smoking on mutation accumulation. This approach has illuminated the interplay between smoking and aging in driving carcinogenesis.

For decades, researchers struggled to confirm the theory that smoking causes lung cancer by inducing DNA mutations. Sequencing errors in earlier methods made it difficult to distinguish true mutations from noise, delaying progress. However, breakthroughs in single-cell genomics have overcome these limitations.

Jan Vijg, Ph.D., a leading expert in molecular genetics, developed a novel sequencing technique called single-cell multiple displacement amplification (SCMDA). This method, first described in Nature Methods in 2017, minimizes errors and improves the accuracy of mutation detection.

Researchers from the Albert Einstein College of Medicine recently used SCMDA to study lung cells from 14 non-smokers aged 11 to 86 and 19 smokers aged 44 to 81. Smokers in the study had a maximum smoking history of 116 pack-years.

The team collected bronchial epithelial cells during diagnostic bronchoscopies. These cells, among the most likely to develop into cancer, accumulate mutations from both aging and smoking. By comparing mutation rates in these groups, researchers have begun to decode the molecular footprint of smoking and its role in lung cancer risk.

The study published in Nature Genetics, revealed that lung cells accumulate mutations as individuals age, with smokers showing significantly higher mutation rates than non-smokers. These mutations include single-nucleotide variants and small insertions or deletions. The findings reinforce the hypothesis that smoking accelerates mutation accumulation, increasing cancer risk. This aligns with broader epidemiological data showing that lung cancer is rare among non-smokers, while 10-20% of lifelong smokers develop the disease.

Interestingly, the number of mutations in smokers’ lung cells rose proportionally with pack-years of smoking but plateaued after approximately 23 pack-years. This ceiling suggests a biological limit to mutation accumulation, even in heavy smokers. According to Simon Spivack, M.D., a pulmonologist and co-senior author of the study, this plateau may reflect enhanced DNA repair mechanisms or detoxification systems in some individuals.

“The individuals who smoked the most didn’t have the highest mutation burden,” said Dr. Spivack. “This indicates that their systems may effectively counteract further DNA damage, allowing them to survive despite prolonged exposure to cigarette smoke.”

These findings open the door to new approaches in lung cancer research. Identifying the molecular mechanisms that protect certain smokers could lead to targeted interventions for those at higher risk.

Dr. Vijg emphasized the importance of developing assays to measure an individual’s capacity for DNA repair or detoxification. Such tools could revolutionize risk assessment and early detection strategies.

Dr. Spivack highlighted the broader implications of this research: “This may prove to be an important step toward the prevention and early detection of lung cancer risk and away from the current herculean efforts needed to battle late-stage disease, where the majority of health expenditures and misery occur.”

By combining advanced genomic techniques with epidemiological insights, researchers hope to move closer to personalized cancer prevention. This approach could help identify at-risk individuals before symptoms arise, improving outcomes and reducing the burden of late-stage disease.

The research underscores the importance of bridging molecular biology and clinical practice. While smoking cessation remains the most effective way to reduce lung cancer risk, understanding the genetic and molecular basis of cancer resilience offers new hope. The ability to pinpoint individuals who are more vulnerable to the harmful effects of smoking could enable earlier interventions and better allocation of healthcare resources.

As scientists continue to refine single-cell sequencing techniques, the potential for breakthroughs in cancer prevention and treatment grows. This research not only advances our understanding of lung cancer but also sets the stage for innovations in precision medicine. By unraveling the complex interplay of age, smoking, and genetic resilience, researchers are paving the way for a future where lung cancer is not only treatable but preventable.

According to the Cleveland Clinic, tobacco use harms every organ in your body. Smoking tobacco introduces not only nicotine but also more than 5,000 chemicals, including numerous carcinogens (cancer-causing chemicals), into your lungs, blood and organs.

The damage caused by smoking can shorten your lifespan significantly. In fact, smoking is the number one cause of preventable death in the United States.

Pregnant women who smoke put their unborn babies at risk, too. Possible effects on pregnancy include:

In addition to its known cancer risks, the Cleveland Clinic states that smoking causes many other chronic (long-term) health problems that need ongoing care. Specific smoking-related problems that need treatment include:

The study is titled, “Single-cell analysis of somatic mutations in human bronchial epithelial cells in relation to aging and smoking.”

Note: Materials provided above by The Brighter Side of News. Content may be edited for style and length.

Like these kind of feel good stories? Get The Brighter Side of News' newsletter.